The study is aimed at advancing personalized cancer treatment by exploring a personalized approach to radioligand therapy.

The partnership will evaluate whether imaging- and biomarker-informed insights can support a more personalised approach to ...

GEHC and Mayo Clinic collaboration aims to advance adaptive cancer theranostics using imaging, biomarkers and clinical data ...

GE HealthCare and Mayo Clinic today announced the MI-BET (Molecular Imaging Biomarker-Based End of Therapy Trial) research ...

CHICAGO--(BUSINESS WIRE)--GE HealthCare today announced CE Mark for its new StarGuide™ GX system, i a new digital 4D SPECT/CT designed with excellent precision, clinical efficiency and impressive ...

Single-photon emission computerized tomography (SPECT/CT) systems are a key tool to diagnose and monitor diseases, but for the past sixty years the technology has remained more or less the same. This ...

GE Healthcare’s Discovery NM630 – for quicker, lower dose imaging – has just been approved by the Food and Drug Administration. This new system for disease detection and diagnosis is a SPECT scan – or ...

Evercare Hospital Lekki, a state-of-the-art medical facility located in Lagos, has raised the bar in clinical excellence and diagnostic versatility with the procurement and installation of the GE ...

The FINANCIAL — At the Society of Nuclear Medicine this year, GE Healthcare is introducing the latest addition to its Nuclear Medicine 600 series with a new performance SPECT/CT system—the Optima ...

StarGuide GX i empowers personalized care and research innovation as nuclear medicine expands into new applications The system doubles volume sensitivity, ii maintains high resolution and enables ...